/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00Michael Kuhrt/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMichael Kuhrt2020-05-20 15:04:002020-05-20 15:04:00Non-Executive Director for Redx Pharma
https://european-biotechnology.com/wp-content/uploads/2024/04/Allostem.jpg301451Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-05-19 09:07:572020-05-19 09:07:57Vaccine to protect from any viral infection
https://european-biotechnology.com/wp-content/uploads/2024/04/EBM.de_Lumitos_Tosoh_Ad_kl.png15362731Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2020-05-18 14:06:082020-05-18 14:06:08How to purify and analyze your antibodies efficiently
4TEEN4 Pharmaceuticals GmbH published data suggesting that high plasma levels of dipeptidyl peptidase 3 were indicative for upcoming multiple organ failure in burn patients.
Aviv Regev will follow Michael Varney as Head of Genentech Research and Early Development (gRED) at Roche subsidiary Genentech. Varney will retire from the company at the end of July.
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00Michael Kuhrt/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMichael Kuhrt2020-05-13 12:00:182020-05-13 12:00:18Genentech: New Head of Research and Early Development
https://european-biotechnology.com/wp-content/uploads/2024/04/ACIB-Innophore.jpg12322185Uta Mommert/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngUta Mommert2020-05-13 05:28:002020-05-13 05:28:00IMI ramps up COVID fund
https://european-biotechnology.com/wp-content/uploads/2024/04/2020_05_11_rebel_meat.jpg450800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-05-11 23:17:002024-04-02 16:20:25Growing interest in alternative meat market
https://european-biotechnology.com/wp-content/uploads/2024/04/EBM_MOSA_001H-2_sw.jpg442786Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-05-11 14:50:002024-04-02 16:20:26Upscaling in the race to cultured meat
Non-Executive Director for Redx Pharma
AppointmentsFrom the beginning of July, Sarah Gordon Wild will be an Independent non-Executive Director at Redx Pharma in Alderley Park, UK.
SARS-CoV2 antibody tests: not suited for individual diagnosis?
Latest NewsAn international research consortium provides data demonstrating that SARS-CoV-2 antibody tests are only useful for population-based analyses.
Vaccine to protect from any viral infection
Latest NewsTwo companies have presented a novel vaccination concept that might protect risk groups from new SARS-CoV-2 variants.
How to purify and analyze your antibodies efficiently
Sponsored PublicationsChromatography methods and practical tips to simplify and reduce the costs of your processes
Abivax bags €36m fund for COVID-19 programme
Latest NewsFrench Abivax SA has received a €36m non-dilutive funding from Bpifrance for its ABX464 Covid-19 programme.
4Teen4’s DPP3 predicts burn mortality
Latest News4TEEN4 Pharmaceuticals GmbH published data suggesting that high plasma levels of dipeptidyl peptidase 3 were indicative for upcoming multiple organ failure in burn patients.
Genentech: New Head of Research and Early Development
AppointmentsAviv Regev will follow Michael Varney as Head of Genentech Research and Early Development (gRED) at Roche subsidiary Genentech. Varney will retire from the company at the end of July.
IMI ramps up COVID fund
Latest NewsThe funding pot of the Innovation Medicines Initiative has been boosted to €117m. IMI has also selected eight projects to fund.
Growing interest in alternative meat market
BackgroundManufacturers are keen to get involved in the alternative meat market. Investors and incubators are pushing forward start-ups.
Upscaling in the race to cultured meat
BackgroundA first wave of cultured meat companies is pushing forward. European start-ups such as Mosa Meat and Peace of Meat are part of the game.